nrf2 and biallelic fh inactivation
Published 3 years ago • 212 plays • Length 16:12Download video MP4
Download video MP3
Similar videos
-
9:45
response to systemic therapy in patients with metastatic fumarate hydratase (fh) deficient rcc
-
30:39
into the light: understanding and treating rare kidney cancers
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
2:10
how to evaluate options following a kidney cancer diagnosis | national kidney foundation
-
1:31
risk factors and symptoms of renal (kidney) cancer
-
0:23
kidney cancer trial (the radical study)
-
2:42:40
part two - kidney cancer association national patient conference
-
0:39
kidney cancer 💉💊🩹🩺
-
1:26
what is papillary rcc?
-
0:35
potential of immunotherapy for kidney cancer
-
0:51
how rare is kidney cancer and what are the subtypes?
-
2:49
il 2 vs interferon for treatment of advanced kidney cancer
-
1:29
cancer research: immunotherapy combination shows promise in kidney cancer
-
1:33
what treatment options do people with rare types of kidney cancer have?
-
0:47
understanding kidney cancer risk factors
-
2:10
understanding immunotherapy in treatment for kidney cancer
-
6:34
kidney cancer – an introduction
-
0:58
kidney cancer scan types | national kidney foundation